The cobas pulse system can improve the patient's blood glucose management

Introduction: Recently, Roche launched the cobas pulse system in some countries that accept CE certification. This system is the solution for professional blood glucose management. The cobas pulse system is portable and uses an Android-based interface that makes it as easy to use as a smartphone.

On January 12, 2022, Roche announced the launch of the COBAS pulse system in countries that are CE certified. The cobas pulse system marks Roche Diagnostics' latest generation of networked point-of-care solutions for professional blood glucose management. An industry first, the cobas pulse system combines the form factor and ease of use of a high-performance blood glucose meter with extended digital capabilities similar to smartphones.

Glucose is one of the most important biomarkers for assessing patient health and predicting, diagnosing, and managing metabolic diseases. Management of patient glucose is essential to prevent acute and chronic complications that can lead to increased morbidity, mortality and medical costs. In the context of the growing prevalence of diabetes and other noncommunicable diseases, health systems and professionals need to undertake this critical intervention on a regular basis.

Diabetes is a relatively common condition, it requires lifelong treatment, and the root of treatment is to control blood sugar. Blood glucose management of diabetics is very important, related to the follow-up physical health problems, if blood glucose management is not in place, it is easy to have a series of diabetic complications. Therefore, diabetics must insist on regularly checking their own blood glucose status, and must monitor their blood sugar in real time, so as to cope with some emergencies. Whether in terms of exercise or diet, be sure to monitor your blood sugar regularly.

Designed for professional use in a variety of nursing settings where timely and informed clinical decisions are required, the cobas pulse system introduces advanced technologies designed to greatly streamline the workflow of busy nurses and doctors and improve their ability to deliver care.

The Cobas Pulse System is Roche's latest generation of networked professional blood glucose management solutions developed on the basis of Accu-Chek Inform II. The cobas pulse system is designed with advanced safety and performance, simplicity and enhanced digital capabilities at its core, and is the gateway to the digital health of the future. The system can improve workflows, benefit cost-effectiveness and improve patient care. The cobas pulse system is reliable and safe to use in all professional care settings (including intensive care) and in patients of all ages, including newborns.

The cobas pulse system performs well and meets the standards of one of the latest guidelines for blood glucose meters. It is undisturbed, has an easy to clean and robust design that can be cleaned and disinfected 12,000 times. The portability of the cobas pulse system and the intuitive interface based on the Android system make it as simple to use as a smartphone. Among several other innovations, the COBAS pulse system has a luminous glucose bar port for easy use in low-light environments, wireless charging, an embedded camera for multiple uses, and a secure RFID badge. The cobas system is equipped with Roche's selected digital health applications, enabling a truly diverse range of operations for patient and workflow management.

After the first commercial supply under the CE marking in selected markets, Roche plans to seek ce IVDR and FDA licenses for cobas pulse systems in other markets around the world throughout 2022.